Núria Sabé

4.9k total citations
64 papers, 2.9k citations indexed

About

Núria Sabé is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Núria Sabé has authored 64 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 19 papers in Infectious Diseases and 8 papers in Pharmacology. Recurrent topics in Núria Sabé's work include Pneumonia and Respiratory Infections (16 papers), Pneumocystis jirovecii pneumonia detection and treatment (15 papers) and Cytomegalovirus and herpesvirus research (14 papers). Núria Sabé is often cited by papers focused on Pneumonia and Respiratory Infections (16 papers), Pneumocystis jirovecii pneumonia detection and treatment (15 papers) and Cytomegalovirus and herpesvirus research (14 papers). Núria Sabé collaborates with scholars based in Spain, United States and Australia. Núria Sabé's co-authors include Jordi Carratalà, Francesc Gudiol, Jordi Dorca, Frederic Manresa, R. Verdaguer, Beatriz Rosón, Fé Tubau, Marta Bodro, Laura Lladó and F. Manresa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Núria Sabé

59 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Núria Sabé Spain	30	2.1k	539	512	420	355	64	2.9k
R. Verdaguer Spain	31	1.8k 0.8×	693 1.3×	523 1.0×	292 0.7×	350 1.0×	56	2.8k
Manuel Almela Spain	24	2.2k 1.0×	723 1.3×	886 1.7×	755 1.8×	161 0.5×	51	3.5k
Mats Kalin Sweden	31	2.2k 1.1×	302 0.6×	404 0.8×	299 0.7×	316 0.9×	71	3.2k
Florent Wallet France	32	1.3k 0.6×	865 1.6×	632 1.2×	395 0.9×	225 0.6×	167	3.2k
Joseph F. Plouffe United States	28	3.1k 1.5×	538 1.0×	865 1.7×	338 0.8×	526 1.5×	57	4.5k
John D. Rihs United States	27	1.3k 0.6×	350 0.6×	1.2k 2.3×	443 1.1×	153 0.4×	47	3.2k
Krow Ampofo United States	37	2.7k 1.3×	232 0.4×	779 1.5×	238 0.6×	226 0.6×	109	3.6k
Albert Gabarrús Spain	31	2.0k 1.0×	732 1.4×	387 0.8×	231 0.6×	410 1.2×	99	3.0k
José Bordón United States	24	1.3k 0.6×	196 0.4×	376 0.7×	288 0.7×	222 0.6×	69	2.1k
José Mensa Spain	34	3.2k 1.5×	642 1.2×	2.1k 4.1×	525 1.3×	342 1.0×	117	5.3k

Countries citing papers authored by Núria Sabé

Since Specialization

Citations

This map shows the geographic impact of Núria Sabé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Núria Sabé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Núria Sabé more than expected).

Fields of papers citing papers by Núria Sabé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Núria Sabé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Núria Sabé. The network helps show where Núria Sabé may publish in the future.

Co-authorship network of co-authors of Núria Sabé

This figure shows the co-authorship network connecting the top 25 collaborators of Núria Sabé. A scholar is included among the top collaborators of Núria Sabé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Núria Sabé. Núria Sabé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pérez‐Recio, Sandra, Jordi Guardiola, Xavier Juanola, et al.. (2025). Prevention of Tuberculosis in Patients Treated With Biological Therapies: 20 Years' Experience in a Specialized Tuberculosis Clinic in a Low-prevalence Country. Clinical Infectious Diseases. 82(2). 282–290.

Frutos, Fernando de, et al.. (2025). Challenges in the Management of Refractory Cytomegalovirus Infection in a Heart Transplant Recipient. The Journal of Heart and Lung Transplantation. 44(4). S246–S246.

Favà, Alexandre, Laura Calatayud, Edoardo Melilli, et al.. (2024). Hybrid immunity protection against SARS-CoV-2 and severe COVID-19 in kidney transplantation: A retrospective, comparative cohort study. American Journal of Transplantation. 24(12). 2282–2291. 1 indexed citations

Martí, Sara, Núria Sabé, L. Riera, et al.. (2023). Randomized clinical trial of non-antibiotic prophylaxis with d-Mannose plus Proanthocyanidins vs. Proanthocyanidins alone for urinary tract infections and asymptomatic bacteriuria in de novo kidney transplant recipients: The Manotras study. SHILAP Revista de lepidopterología. 44(3). 408–416.

Rombauts, Alexander, Marta Bodro, Victor Daniel Gumucio, et al.. (2023). Antifungal prophylaxis with nebulized amphotericin-B in solid-organ transplant recipients with severe COVID-19: a retrospective observational study. Frontiers in Cellular and Infection Microbiology. 13. 1165236–1165236. 4 indexed citations

Oriol, Isabel, Mayli Lung, Laura Lladó, et al.. (2023). Impact of Prophylactic Norfloxacin in Multidrug Resistant Bacterial Infections in the Early Liver Posttransplant Period. Experimental and Clinical Transplantation. 21(3). 236–244. 1 indexed citations

Sabé, Núria, Josep M. Cruzado, & Jordi Carratalà. (2020). Asymptomatic bacteriuria in kidney transplant recipients: to treat or not to treat—that is the question. Clinical Microbiology and Infection. 27(3). 319–321. 3 indexed citations

Oriol, Isabel, Laura Lladó, Carme Baliellas, et al.. (2016). The Etiology, Incidence, and Impact of Preservation Fluid Contamination during Liver Transplantation. PLoS ONE. 11(8). e0160701–e0160701. 16 indexed citations

Oriol, Isabel, Núria Sabé, Edoardo Melilli, et al.. (2015). Factors influencing mortality in solid organ transplant recipients with bloodstream infection. Clinical Microbiology and Infection. 21(12). 1104.e9–1104.e14. 20 indexed citations

10.

Martínez‐Atienza, Juliana, Clara Rosso-Fernández, Cristina Roca-Oporto, et al.. (2014). Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: study protocol for a multicenter, randomized, controlled clinical trial. Trials. 15(1). 338–338. 3 indexed citations

11.

López‐Medrano, Francisco, Elisa Cordero, Joan Gavaldà, et al.. (2013). Executive summary. Management of influenza infection in solid-organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI). Enfermedades Infecciosas y Microbiología Clínica. 31(8). 528–534. 1 indexed citations

12.

Bodro, Marta, Núria Sabé, Laura Lladó, et al.. (2012). Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients. Liver Transplantation. 18(9). 1093–1099. 38 indexed citations

13.

Sabé, Núria, José González‐Costello, Inés Rama, et al.. (2012). Successful outcome of ganciclovir-resistant cytomegalovirus infection in organ transplant recipients after conversion to mTOR inhibitors. Transplant International. 25(7). e78–e82. 23 indexed citations

14.

Carratalà, Jordi, Carolina García‐Vidal, Lucía Ortega, et al.. (2012). Effect of a 3-Step Critical Pathway to Reduce Duration of Intravenous Antibiotic Therapy and Length of Stay in Community-Acquired Pneumonia. Archives of Internal Medicine. 172(12). 922–8. 100 indexed citations

15.

Cordero, Elisa, Pilar Pérez‐Romero, Asunción Moreno, et al.. (2011). Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and non-viral co-infection. Clinical Microbiology and Infection. 18(1). 67–73. 50 indexed citations

16.

Dorca, Jordi, Carolina García‐Vidal, Núria Sabé, et al.. (2011). Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Critical Care. 15(2). R96–R96. 114 indexed citations

17.

Sabé, Núria, Carlos Cervera, María Carmen Fariñas, et al.. (2011). Risk Factors, Clinical Features, and Outcomes of Toxoplasmosis in Solid-Organ Transplant Recipients: A Matched Case-Control Study. Clinical Infectious Diseases. 54(3). 355–361. 86 indexed citations

18.

García‐Vidal, Carolina, Jordi Carratalà, Núria Sabé, et al.. (2009). Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clinical Microbiology and Infection. 15(11). 1033–1038. 53 indexed citations

19.

Carratalà, Jordi, Núria Sabé, Jordi Dorca, et al.. (2005). Clinical Outcomes for Hospitalized Patients with Legionella Pneumonia in the Antigenuria Era: The Influence of Levofloxacin Therapy. Clinical Infectious Diseases. 40(6). 794–799. 94 indexed citations

20.

Carratalà, Jordi, et al.. (2003). Factors Associated with Complications and Mortality in Adult Patients Hospitalized for Infectious Cellulitis. European Journal of Clinical Microbiology & Infectious Diseases. 22(3). 151–157. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact